SCHEMBL14485284

SCHEMBL14485284

COC(=O)CCc1cc(I)c(Oc2ccc(OC)c(C(=O)NCc3ccccc3)c2)c(I)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.51
▸ TP53 P04637 1/20 0.51
▸ GLA P06280 1/20 0.51
▸ PPARA Q07869 9/20 0.48
▸ PPARG P37231 5/20 0.48
▸ PPARD Q03181 2/20 0.48
▸ BRD4 O60885 1/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ AKR1C3 P42330 1/20 0.44
▸ THRA P10827 3/20 0.44
▸ THRB P10828 3/20 0.44
▸ POLB P06746 1/20 0.44
▸ PCNA P12004 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HIF1A Q16665 1/20 0.44
▸ MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16124500 0.87 SMN1; SMN2 (0.48) TP53MEN1KMT2AAKR1C3THRA
SCHEMBL14484723 0.86 PCNA (0.51) HPGDPPARGALDH1A1KMT2ATHRA
SCHEMBL16124501 0.80 THRB (0.65) HPGDPPARGTHRATHRBPOLB
SCHEMBL16124463 0.77 PCNA (0.53) ALDH1A1THRATHRBPOLBPCNA
SCHEMBL14484785 0.77 PCNA (0.48) HPGDPPARGMEN1KMT2ATHRA
SCHEMBL14485257 0.76 PCNA (0.61) MEN1ALDH1A1KMT2ATHRATHRB
SCHEMBL16124418 0.76 PCNA (0.63) HPGDPPARGTHRATHRBPOLB
SCHEMBL16124422 0.76 PCNA (0.56) THRATHRBPOLBPCNAMAPK1
SCHEMBL21296316 0.73 NPC1 (0.59) HPGDTP53GLAMEN1ALDH1A1
SCHEMBL12642750 0.73 PCNA (0.74) THRATHRBPOLBPCNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 — — US disclosed
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2014-09-25 — — US disclosed
WO-2013006734-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY ST. JUDE CHILDREN'S RESEARCH HOSPITAL (US) 2013-01-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140288077-A1 SUBSTITUTED 4-PHENOXYPHENOL ANALOGS AS MODULATORS OF PROLIFERATING CELL NUCLEAR ANTIGEN ACTIVITY MKI67, PCNA, PCLAF HPGD 1358/4885TP53 5/4885GLA 2214/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback